Barclays Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its target price dropped by equities research analysts at Barclays from $1,600.00 to $1,550.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective points to a potential upside of 11.75% from the company’s current price.

Other equities research analysts also recently issued research reports about the company. Morgan Stanley assumed coverage on Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 target price for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 8th. Stifel Nicolaus increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. The Goldman Sachs Group started coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 target price on the stock. Finally, Wells Fargo & Company raised their price target on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Stock Down 1.8%

MTD opened at $1,387.07 on Monday. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,525.17. The company has a 50 day moving average of $1,405.14 and a two-hundred day moving average of $1,297.26. The company has a market cap of $28.34 billion, a P/E ratio of 34.59, a P/E/G ratio of 4.56 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same quarter last year, the firm posted $10.21 EPS. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Research analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 236 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the sale, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. This trade represents a 59.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 474 shares of Mettler-Toledo International stock in a transaction on Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the completion of the sale, the director owned 311 shares of the company’s stock, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Hedge funds have recently bought and sold shares of the company. Versant Capital Management Inc raised its stake in Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares in the last quarter. SJS Investment Consulting Inc. increased its holdings in shares of Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares during the last quarter. Salomon & Ludwin LLC acquired a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at approximately $43,000. Root Financial Partners LLC bought a new position in Mettler-Toledo International during the third quarter worth $42,000. Finally, WPG Advisers LLC bought a new position in Mettler-Toledo International during the first quarter worth $41,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.